Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by GRAMPS1996on Oct 20, 2017 7:56am

129 Views

Post# 26835417

Busy week for Theralase conferences and tradeshows

October 19 - 22, 2017

Canadian Podiatric Conference 2017 (in association with Ontario Podiatric Medical Association)
Delta Hotels Toronto Airport & Conference Centre
655 Dixon Road, Toronto, ON M9W 1J3, Canada
Booth #TBD

Featuring Theralase Guest Speaker: Dr. Ben Sefcik, DPM

October 19 - 22, 2017

28th A.M of the Academy of Integrative Pain Management
Hilton San Diego Bayfront
1 Park Blvd, San Diego, California 92101, USA
Booth #126

October 20 - 22, 2017

105th Annual Fall Conference & Trade Show (in association with Georgia Chiropractic Association)
The Westin Atlanta Perimeter North
7 Concourse Parkway NE, Atlanta, GA, 30328, USA
Booth #104